Replies to post #358621 on Anavex Life Sciences Corp (AVXL)

[kund]

prophylactic market? Guy cannot complete tiny rett trial for last 2 1/2 year and talking about prophylactic market. In 2015 Misleading paid news said messiah will rise and world will notice him, I guess that day is coming....LOL

[plexrec]

jmv--"is confirmed in the AD phase 2b/3 trial later this year, "--is what all here are waitng for !!! hopefuly we see the day !!!!!

[RedShoulder]

Red & plexrec,

I watched this mornings presentation and will say that TGD is coming off as very comfortable and confident in making these presentations. The Stock Twits post sums it up quite well but I also feel TGD is doing a better job of explaining all the upstream
benefits of 2-73 and how much better it is than a drug that just targets amyloid/tau.

Early on in his presentation, he definitely covered the potential prophylactic market,
talking about how the animal studies showed 2-73 prevented AD. Once the MOA
is confirmed in the AD phase 2b/3 trial later this year, Wall Street might finally start
factoring in the enormous size of the prevention market in their calculations for
Anavex.
jmvho

jmvho, thanks for you report. I'm looking forward to seeing the PR on the last patient completing and closing the trial next month. That news should get widely published in the financial news articles. Obviously anyone paying attention has been seeing AVXL left out of Alzheimer articles while other bios in AD programs years behind Anavex getting plenty of ink. When new financial articles are out that Anavex has completed it's trial, that should get this Vol and SP moving up.

Today the XBI being down one percent did not help, Anavex has been pretty much tracking the XBI, however good Alzheimer news should break Anavex away from the XBI down trend.